SL
RNAM

Salomon & Ludwin’s Avidity Biosciences RNAM Stock Holding History

Salomon & Ludwin’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-193
Closed -$13.9K – 2173
2025
Q4 		$13.9K Hold
193
– – ﹤0.01% 1192
2025
Q3 		$9.07K Buy
+193
New +$7.8K ﹤0.01% 1384

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Salomon & Ludwin's RNAM Position: Q1 2026 in Review

Salomon & Ludwin sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 193 shares — an estimated $13.9K sold.

Salomon & Ludwin first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $13.9K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Salomon & Ludwin reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Salomon & Ludwin sold 193 Avidity Biosciences shares in Q1 2026, an estimated $13.9K.
  • Salomon & Ludwin first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
  • Salomon & Ludwin's Avidity Biosciences position peaked at $13.9K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.